Credit Suisse Downgrades Esperion Therapeutics To Neutral
June 24, 2015 at 09:50 AM EDT
Credit Suisse downgraded Esperion Therapeutics Inc (NASDAQ: ESPR) from Outperform to Neutral. The price target for Esperion ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.